Biological evaluation of the effect of sugammadex on hemostasis and bleeding

Biological evaluation of the effect of sugammadex on hemostasis and bleeding

BackgroundNotification of sugammadex has been supplemented with a section on hemostasis, including a longer clotting time in the first minutes following injection, without any documented clinical consequences. The objective of this observational study was to analyze the effects of sugammadex adminis...

Full description

Bibliographic Details
Main Authors:	Julien Raft, Philippe Guerci, Valentin Harter, Thomas Fuchs-Buder, Claude Meistelman
Format:	Article
Language:	English
Published:	Korean Society of Anesthesiologists 2015-02-01
Series:	Korean Journal of Anesthesiology
Subjects:	activated partial thromboplastin time hemostasis prothrombin time sugammadex
Online Access:	http://ekja.org/upload/pdf/kjae-68-17.pdf

Similar Items

Sugammadex: clinical development and practical use
by: Thomas Fuchs-Buder, et al.
Published: (2013-12-01)

Periprocedural Coagulation Status in Percutaneous Interventions
by: Soumil Singhal, et al.
Published: (2019-12-01)

Unified Methodology for the Primary Preclinical In Vivo Screening of New Anticoagulant Pharmaceutical Agents from Hematophagous Organisms
by: Maria A. Kostromina, et al.
Published: (2024-04-01)

Potential Anticoagulant Activity of Thymus atlanticus Leaves Part in vitro on Normal Plasma Samples
by: Mothana Abdullah Elhussein, et al.
Published: (2022-06-01)

The changes in the fibrinogen concentration and coagulation pathways in winter and summer in cattle
by: ameneh khoshvaghti
Published: (2013-08-01)

Within- and between-subject biological variation of hemostasis parameters in a study of 26 healthy individuals
by: Zengi Oguzhan, et al.
Published: (2023-08-01)

The frequency and timing of sepsis-associated coagulopathy in the neonatal intensive care unit
by: Khyzer B. Aziz, et al.
Published: (2024-03-01)

Effect of plasma storage on prothrombin time and activated partial thromboplastin time at a Nigerian public laboratory
by: Mohammed A Ndakotsu, et al.
Published: (2013-01-01)

Prothrombin time and activated partial thromboplastin time in women with gestational diabetes mellitus
by: Samira Mahjabeen, et al.
Published: (2023-01-01)

Variations in activated partial thromboplastin time and prothrombin time in individuals of A, B, AB, and O blood groups
by: Chizoba Okechukwu Okeke, et al.
Published: (2018-01-01)

Green tea consumption effects on coagulation profile
by: Ahmed Mohammed Elnour Elkhalifa, et al.
Published: (2020-01-01)

Hemostatic abnormalities in children with thalassemia major and liver iron overload
by: Pustika Amalia Wahidiyat, et al.
Published: (2018-08-01)

Sickle cell disease: Assessment of hemostasis parameters in steady-state patients at Tertiary Care Hospital, Indore, India
by: Gajendra Kumar Gupta, et al.
Published: (2022-01-01)

Evaluation of anticoagulant and thrombolytic activity of Berberis orthobotrys in animal model
by: . Alamgeer, et al.
Published: (2018-06-01)

Establishing reference ranges and normal values for coagulation screening in healthy Indian male volunteers enrolled for a longitudinal study
by: Rehan Ahmed, et al.
Published: (2019-01-01)

Coagulation profile alterations in dogs co-infected with visceral leishmaniasis and monocytic ehrlichiosis
by: Canberk BALIKÇI, et al.
Published: (2023-09-01)

Coagulation abnormalities and their relationship with bleeding manifestations in patients with dengue-A single center observational study
by: Govind R Patel, et al.
Published: (2023-01-01)

Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays
by: Mohammadali Boroumand, et al.
Published: (2010-04-01)

Effect of Haemodialysis on Mean Prothrombin Time and Activated Partial Thromboplastin Time in Patients of End Stage Renal Disease
by: Attika Khalid
Published: (2015-12-01)

Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays
by: Hamidreza Goodarzynejad, et al.
Published: (2010-05-01)

Effect of anticoagulant adjustment on prothrombin time test using two different PT reagents in patients with elevated hematocrit
by: Vanessa M. Silva, et al.
Published: (2020-11-01)

Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
by: Osamu Kumano, et al.
Published: (2021-03-01)

Activation of coagulation system and d-dimer levels in children with acute leukemia
by: Harun Wijaya, et al.
Published: (2014-08-01)

The Influence of Sustained Mercury Exposure on Prothrombin Time and Partial Thromboplastin Time among Sudanese Gold Mining Workers
by: Rimonda Emil Tadros, et al.
Published: (2022-06-01)

Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and Art Status
by: R Thulasi Raman, et al.
Published: (2016-05-01)

PBL Case on Child Abuse/Hemophilia A
by: Niels Larsen, et al.
Published: (2009-09-01)

Prolonged APTT of unknown etiology: A systematic evaluation of causes and laboratory resource use in an outpatient hemostasis academic unit
by: Ayla Cristina Nóbrega Barbosa, et al.
Published: (2019-10-01)

Hemostatic changes in patients with chronic renal failure
by: Harith Y. Serrheed, et al.
Published: (2018-09-01)

Is there any effect of pneumoperitoneum pressure on coagulation and fibrinolysis during laparoscopic cholecystectomy?
by: Turgut Donmez, et al.
Published: (2016-09-01)

Study of coagulation profile in patients admitted to a trauma center in a tertiary care hospital
by: Kalpana Ketan Kulkarni, et al.
Published: (2021-01-01)

Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models
by: Juan A. De Pablo-Moreno, et al.
Published: (2022-03-01)

Response of Coagulation Indices to Two Types of Exercise of Eccentric and Isometric in Male Bodybuilding Athletes
by: Maryam Azimpour, et al.
Published: (2016-05-01)

Analysis of D-Dimer Level and Prothombin Time (PT) Activated Prothombin Thromboplastin (APTT) on Heparin Administration to COVID-19 Patients
by: Dela Yorike, et al.
Published: (2022-04-01)

Effect of magnesium sulfate on blood coagulation status in pregnant women with preeclampsia
by: Maryam Kashanian, et al.
Published: (2021-02-01)

Traumatic Tonsillar Hemorrhage during Hemophilia A Treatment with Emicizumab
by: Fumiya Inoue, et al.
Published: (2022-03-01)

Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban
by: Tze-Fan Chao, et al.
Published: (2022-12-01)

Influence of Oral Dipping Tombak Smokeless Tobacco on Coagulation Profile and Platelet Counts
by: Ahmed M. E. Elkhalifa, et al.
Published: (2022-04-01)

The Association between Blood Coagulation Parameters and Glasgow Coma Scale in Patients with Head Trauma Admitted to Intensive Care Unit
by: Azadeh Bahadori, et al.
Published: (2018-10-01)

Comparative analysis of platelet depleted plasma prepared on the Roche 8100 automation line and manually centrifuged platelet poor plasma for routine coagulation assays
by: Mustafa A. Barbhuiya, et al.
Published: (2023-08-01)

Determination of prothrombin time and activated partial thromboplastin time in newly diagnosed untreated cases of type-2 diabetes mellitus at the University of Nigeria teaching hospital, Enugu
by: E O Ukaejiofo, et al.
Published: (2007-01-01)